Back
Adaptimmune Therapeutics PLC Vs. Verona Pharma PLC Industry Stock Comparison
Sell
27
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.68
Seasonality Move:
53.66%
Buy
73
VRNA
Verona Pharma PLC
Last Price:
39.83
Seasonality Move:
25.3%
Sell
27
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.68. The Score for ADAP is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
73
Verona Pharma PLC (VRNA)
is a Buy
Is Verona Pharma PLC a Buy, Sell or Hold?
- The current Verona Pharma PLC [VRNA] share price is $39.84. The Score for VRNA is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- VRNA is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $0.68
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing selling pressure, which indicates risk of future bearish movement.
VRNA Stock Price Chart
What is Verona Pharma PLC's stock price today?
-
The Verona Pharma PLC share price today is $39.84
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRNA is experiencing buying pressure, which is a positive indicator for future bullish movement.
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 42.73 | Sell |
| Chaikin Money Flow: | -263450 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.66 - 0.8) | Sell |
| Bollinger Bands (100): | (0.79 - 1.21) | Sell |
VRNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.43 | Buy |
| Relative Strength Index (14 RSI): | 63.82 | Buy |
| Chaikin Money Flow: | 599413 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.57 - 38.95) | Buy |
| Bollinger Bands (100): | (23.27 - 35.09) | Buy |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.65 | Buy |
| 20-day SMA: | 0.72 | Sell |
| 50-day SMA: | 0.82 | Sell |
| 200-day SMA: | 1.11 | Sell |
| 8-day EMA: | 0.68 | Buy |
| 20-day EMA: | 0.71 | Sell |
| 50-day EMA: | 0.82 | Sell |
| 200-day EMA: | 0.99 | Sell |
VRNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.97 | Buy |
| 20-day SMA: | 37.44 | Buy |
| 50-day SMA: | 33.93 | Buy |
| 200-day SMA: | 22.24 | Buy |
| 8-day EMA: | 38.52 | Buy |
| 20-day EMA: | 37.26 | Buy |
| 50-day EMA: | 34.2 | Buy |
| 200-day EMA: | 25.29 | Buy |
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.33 per share.
Verona Pharma PLC Earnings Growth & VRNA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.73 per share, and an increase next year of $1.40 per share.
Adaptimmune Therapeutics PLC Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Verona Pharma PLC Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||